
Results
2
2 companies
Xiamen Amoytop Biotech
Market Cap: CN¥22.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥55.82
7D
-4.5%
1Y
-20.8%
AcrobiosystemsLtd
Market Cap: CN¥6.4b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥40.39
7D
10.3%
1Y
4.1%